LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing Articles

Can this year’s biggest FTSE 250 winners keep it going in 2019?

2018 has been a great year for the top FTSE 250 (INDEXFTSE: MCX) stocks. Will 2019 see their strong run…

Read more »

Investing Articles

The BT share price soars by 20%. Here’s why I think it could beat the FTSE 100

BT Group plc (LON: BT.A) could offer further growth potential versus the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

FTSE 100 crash? Is this the best stock to hold in case it happens?

Should you be looking for 'picks-and-shovels' plays in case the FTSE 100 (INDEXFTSE: UKX) is heading for a fall?

Read more »

Investing Articles

Is Hikma Pharmaceuticals the hottest growth stock in the FTSE 250?

FTSE 250 (INDEXFTSE: MCX) growth stock Hikma Pharmaceuticals plc (LON: HIK) is up 120% since March. Are there more gains…

Read more »

Investing Articles

Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc

I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why is the Burberry share price up 20% so far this year?

Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround.

Read more »

Investing Articles

2 super growth stocks I’d buy with £5,000 today

Just £5,000 could help you make a fortune with these super growth stocks.

Read more »

Investing Articles

2 cheap growth stocks I’d buy for the long term

These two shares could offer a mix of growth and value in current market conditions.

Read more »

Investing Articles

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential.

Read more »

Investing Articles

Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys.

Read more »

Investing Articles

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright.

Read more »

Investing Articles

2 turnaround stocks I’d consider buying before 2018

Could these two turnaround stocks beat the market in 2018 and beyond?

Read more »